Diabetes Mellitus, Type 1NCT05107544
Metabolic, Physical Fitness and Mental Health Effects of High Intensity Interval Training (HIIT) in Adolescents With Type 1 Diabetes
A study testing HIGH INTENSITY INTERVAL TRAINING in people with Diabetes Mellitus, Type 1, run by Hospital Las Higueras at 1 site in Chile.
Trial summary
Patients with type 1 diabetes usually present cardiovascular risk factors. Sixty percent of them are overweight or obese, 40% have hypertension, 60% have dyslipidemia, leading to cardiovascular disease as the major cause of death in adults with type 1 diabetes. Read more about this study
- Who is it for?
- Ages 12 to 19 years
- Conditions the study is for
- Diabetes Mellitus, Type 1
- What is being tested?
- HIGH INTENSITY INTERVAL TRAINING
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteChile
- Study dates
- 4 Sep 2021to 4 Apr 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 to 19 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- Adolescents with type 1 diabetes
- Ages: 12-19 years (and in pubertal stage of at least Tanner stage III breast or genitalia)
- HbA1c between 7 and 11.5%
- Total daily insulin dose ≥0.7 units/kg/day.
- Both genders
- Patients treated regularly at Las Higueras Hospital and Guillermo Grant Benavente Hospital.
Who cannot join
- < 1 year of diabetes
- Any medical, mental or physical disability that contraindicates exercise.
- Practice of regular, structured and planned physical exercise outside the project, more than 2 times a week.
- Pregnancy or breastfeeding
- > 1 episode of severe hypoglycemia in the last 6 months
- Eligibility criteria:
Show all 13Show fewer
- If the patient meets the inclusion criteria and does not present exclusion criteria, he/she may proceed to carry out physical evaluations to determine if has the conditions to perform the intervention. The patient may be ineligible for investigation in case of:
- Upon completing the Cafra test, His/her heart rate is> or equal to 160 (20, 23)
- If he/she shows blood pressure compatible with arterial hypertension before or after the initial physical evaluation.
- Definition of arterial hypertension according to the recommendations of the American Academy of Pediatrics (30):
- Blood pressure> or equal to the 95th percentile or> 130/80 mm Hg in adolescents greater than or equal to 13 years.
- If he/she develops any signs of post-exercise musculoskeletal injury (functional impotence, pain or swelling joint)
- In case they present a score ≥11 in the PHQ-9 questionnaire without mental health evaluation.
Trial locations and contacts
1 site in 1 country.
About this study
Patients with type 1 diabetes usually present cardiovascular risk factors. Sixty percent of them are overweight or obese, 40% have hypertension, 60% have dyslipidemia, leading to cardiovascular disease as the major cause of death in adults with type 1 diabetes. Regular exercise can help patients to improve cardiovascular disease risk profile, metabolic control and chronic complications. Recommendations for exercise in children with diabetes are the same as the general population, between ages 8 to 18 years 60 min of physical exercise/day is suggested, including moderate or vigorous aerobic activity (at least 20 minutes), muscle strengthening and bone strengthening activities. Children with type 1 diabetes have poorer physical fitness levels than the non-diabetic peers and it has been described some barriers to meet these recommendations between children and adolescents with type 1 diabetes such as the fear of hypoglycemia, external temperature, work schedule, loss of control of diabetes, a low fitness level. The two types of exercise (aerobic and anaerobic) are recommended in people with diabetes. High intensity interval training involves alternation between brief periods of vigorous exercise and recovery at low to moderate intensity. Has been shown that HIIT is associated with improving aerobic capacity without a detrimental decline in blood glucose in adults with type 1 diabetes and home-based high-intensity interval training reduces barriers to exercise in the same group. The objective of the present study is to propose a HIIT exercise protocol through online modality to a group of adolescents with type 1 diabetes to evaluate the metabolic effects and physical capacity through an analytical, prospective and longitudinal study (before and after) for 3 months. As primary outcome is expected to improve metabolic control shown as an increase in time in range on continuous glucose monitoring and a decrease in glycosylated hemoglobin. And as secondary results, improve the aerobic capacity and resistance strength, lipid profile parameters, anthropometric and on the mood of the participants.
Read the detailed description
Hypothesis Three month HIIT training program increases time in range (TIR) and decreases glycemic variability (MAGE) in adolescents with DM1.
HIIT training program improves physical fitness (aerobic capacity and strength) of adolescents with DM1.
Methodology Analytical, prospective, longitudinal study (before and after). This type of study was chosen for ethical reasons. A group will not be left without intervention knowing the benefits of physical exercise in patients with DM1.
HIIT for 3 months
Population of study This study will be carried out with adolescents with type 1 diabetes treated at the sponsoring Hospitals: Las Higueras and Guillermo Grant Benavente.
A sample size of 30 Adolescents would be sufficient to detect a 15 percent increase in the percentage of time in the range of glucose values within the target range four months after the study start using a level of significance of 0.05% a power of 80% and a loss of follow-up of 15% (4 adolescents).
Type of sampling Convenience sampling
Procedures
Metabolic control monitoring Continuous glucose monitoring (CGM) will be used continuously during the study period. The duration of the CGM is going to be 7 days each time (Guardian Connect, Medtronic). If the patients are already wearing a CGM, will use the same device and data from these specific times will be collected for analysis.
Blood glucose will be monitored during exercise to make adjustments to therapy if necessary. This will be done by the doctors weekly for the first month and then every 15 days.
The statistical analysis of the continuous glucose monitoring (CGM) will be carried out in 4 moments: before starting the study, the first month after, at 3 months and 3 months after ending the training.
Blood sampling is going to be taken at baseline and at 3 month. will be measured HbA1c and lipid profile.
Total insulin dosing is going to be carefully recorded as units/kg/day during the study.
An insulin sensitivity score (ISS) is going to be calculated using the SEARCH ISS model: logeIS = 4.64725 - 0.02032 × (waist, cm) - 0.09779 × (HbA1c, %) - 0.00235 × (TG, mg/dL; R2 = 0.74 in the initial SEARCH model). This has been validated using the hyperinsulinemic euglycemic clamp, considered the gold standard for insulin sensitivity measures. CGM data are going to be downloaded and used to calculate percent blood glucose at, below, or above target.
The HbA1c and lipid profile will be measured using the Abbott brand model Architect c8000.
Nutritional assessment Nutritional consultation is going to be performed to the participants, in which it will be carried out a body composition analysis using the bioimpedianciometer TANITA TBF-40 at several times: before starting the intervention, at 1 month, at 3 months and at 3 months after finishing the intervention.
Two educational sessions will be performed to participants and parents and / or caregivers on carbohydrate content and glycemic index to reinforce the knowledge acquired throughout the course of the pathology in order to contribute to improve glycemic control. These will be carried out through a digital platform divided into groups of 10 or 15 participants.
In order to know the daily calorie intake and the distribution of macronutrients of the participants, the information from the 24-hour reminder questionnaire will be collected through a telephone call in 4 random days (without prior notice) during the same evaluation times mentioned previously.
Fitness monitoring Before intervention the participants are going to undergo physical evaluation: Cafra test, course-navette test, strength and Physical activity questionnaire for adolescents (PAQ-a) to determine their health-related fitness before applying the protocol. To standardize the sample and avoid cardiovascular risks due to the intensity of the effort, the Cafra test will be applied, which will enable the participant to perform the following tests. This test is used in the evaluation of physical education by the Education Quality Measurement System in the country. At the end of intervention aerobic capacity and resistance strength is going to be evaluated again.
The Cafra test goal is to determine the cardiovascular adaptive capacity of the participants from workloads of medium intensity during walking. If at the end of the test the individual has a heart rate equal to or greater than 160 beats per minute, he should not take the Navette test.
The Navette test is a cardiorespiratory fitness test. The moment in which the individual interrupts the test indicates the cardiorespiratory endurance. In addition, at the time this test is performed, blood pressure will be measured before and at the end, to rule out the presence of baseline or exercise-induced hypertension.
The heart rate will be measured with a heart rate sensor, which indicates in real time the heart rate reached, during the initial and final evaluations and during training sessions.
To evaluate muscular endurance, the abdominal test will be performed in 60 seconds and the largest possible number of push-ups without rest will be carried out. In this way, there will be a record of how the physical condition is before and after applying the protocol.
Adherence to physical training and nutritional consultations will be monitored through the online connection.
Physical training The training is going to have 2 phases, the initial phase and improvement phase, which are going to be differentiated according to work intensity following the recommendations of the American College of Sports Medicine. To prescribe the intensity of exercise karvonen formula is going to be used for which resting heart rate measured for a week is needed.
The methodology of work is going to be High intensity interval training (HIIT) using cardiovascular and endurance exercises using the own weight considering an intensity of 60-75% of the VO2max during the first 4 weeks (initial phase). The frequency of the training is 3 times a week under researcher online supervision between 3 to 7 pm Monday to Friday. During the improvement phase the intensity is going to increase to a 75-85% of the VO2max for 8 week. The intensity and effects of the training will be monitored thought heart rate sensors and the Borg Rating of Perceived Exertion Scale. Post-exercise monitoring, class coordination, reminders and motivation to participate will be performed by online group administered by the researchers.
Two physical education teachers will supervise each session.
Strategies to avoid acute changes in glycemia during training
It will be required that participants check the blood glucose by fingerstick before meals, before and after exercise, at bedtime, and twice a week around midnight.
The amount and type of food are not going to be controlled, but will be asked participants not exercising before or within 90 minutes after a meal . Considering that HIIT is associated to stable glycaemia no changes will be prescribed in fast-acting insulin dose.
For the management of blood glucose levels during the training period (before, during and after each session), a protocol based on the recommendations of the consensus for glycemia management during exercise using continuous glucose monitoring will be used.
Before starting and after completing each training session, a capillary blood glucose measurement will be requested as a safety measure and also in the event of symptoms of hypoglycemia or if the sensor shows or anticipates hypoglycemia.
In addition, when participants first start exercising, according to the midnight glycemia, it may be necessary to reduce the basal insulin dose by 20-50% on the day of exercise.
Participants using an insulin pump will use the same protocol, with a reduction in bolus doses and use of temporary basal on the days of exercise.
Mood evaluation The Patient Health Questionnaire 9 (PHQ-9) will be applied in its version for adolescents, which consists of nine questions designed to evaluate depressive symptoms according to DSM-5 criteria, on an ordinal scale according to the frequency of symptoms (never, some days, more than half of the days, almost every day). The score range is from 0 to 27 points, where higher values indicate a greater probability of a Depressive Episode. This scale is graded into 4 categories: 0-4 (minimal), 5-9 (mild), 10-14 (moderate), 15-19 (moderate to severe), 20-27 (severe). According to recent evidence, a score greater than or equal to 11 is recommended as a cut-off point to determine probable depressive episode in the Chilean population of adolescents. Patients who present a cut-off point higher than this in the initial evaluation will be excluded from protocol and will be referred to child psychiatry care.
To evaluate the effects of exercise on the depressed mood of adolescents, this survey will also be applied at the end of the intervention and 3 months after the intervention.
Blood Pressure Measurement In addition, during the initial evaluation, blood pressure will be measured before and after the physical tests to detect children with suspected hypertension, who as detailed above will be excluded from the intervention.
The BP recording will be carried out with an oscillometric device and the conditions for this procedure are: the adolescent must be seated, with the right arm uncovered, feet resting on the floor, and the BP cuff at the level of the heart. Before measuring the blood pressure the individual will need to remain sitting for at least five minutes. The blood pressure value will be evaluated according to the recommendations for the diagnosis of hypertension in children and adolescents of the American Academy of Pediatrics.
Statistical Analysis The initial analysis will examine data distribution through the Shapiro-Wilk test and baseline characteristics of all adolescents.
The quantitative variables will be expressed as means or medians, accompanied by deviation or interquartile ranges according to the exploration of normality. It will be analyzed each time of evaluation (transversal) using the chi-square test for categorical variables and the Student-t or Wilcoxon tests for continuous variables.
Relevant tests will be used to consider the non-dependence of the data obtained for both qualitative and quantitative analysis.
The effects of the treatment will be expressed , using mixed regression models (longitudinal) adjusting for potential confounders at baseline.
Subgroup analysis will be performed with interaction tests for relevant variables as BMI and socioeconomic status. Two separate definitions of compliance will be used. First, adolescents will be considered compliant to the HIIT treatment if participation is at least 75% of the number of training. Second, adolescents will be considered compliant to the HIIT if attendance is 100% of the counseling sessions to the nutritional and to endocrine consultations.
Outcome comparisons in the time will be analyzed intention-to-treat basis, regardless of whether is abandoned the study or fully adhere to the intervention. A secondary per-protocol analysis will be performed for the primary outcome including only the adolescents who were compliant with the protocol.
All analyses will follow a pre-specified statistical analysis plan. Stata v.14 software (StataCorp, College Station, TX) will be used for statistical analysis.
- Conditions
- Diabetes Mellitus, Type 1
- Being tested
- HIGH INTENSITY INTERVAL TRAINING
- Medical subject headings
- Diabetes Mellitus, Type 1
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
HIGH INTENSITY INTERVAL TRAININGOther
Will be prescribed HIIT through online modality to a group of adolescents with type 1 diabetes 3 times a week for 3 months. The training is going to have 2 phases, the initial phase and improvement phase, which are going to be differentiated according to work intensity following the recommendations of the American College of Sports Medicine. During the initial phase (first 4 weeks) the intensity is going to be 60-75% of the VO2 max. During the improvement phase the intensity is going to increase to a 75-85% of the VO2 max for 8 week.
| Study group | Role | What they receive |
|---|---|---|
| High Intensity Interval Training | Experimental | The entire group is going to be undergo the intervention Receives: Other: HIGH INTENSITY INTERVAL TRAINING |
What is being measured
The primary outcome is the main question the study is designed to answer.
Time change in range
Time in Range (TIR) is the percentage of time that a person spends with their blood glucose levels in a target range (70-180)
Measured: First month after starting training
Time change in range
Time in Range (TIR) is the percentage of time that a person spends with their blood glucose levels in a target range (70-180)
Measured: Three months after starting training
Time change in range
Time in Range (TIR) is the percentage of time that a person spends with their blood glucose levels in a target range (70-180)
Measured: Three months after finishing training
Secondary outcomes (26)
Change in hemoglobin A1c
Blood test
Measured: Three months after starting training
Change in hemoglobin A1c
Blood test
Measured: Three months after finishing training
Change in cholesterol
Blood test
Measured: Three months after starting training
Change in cholesterol
Blood test
Measured: Three months after finishing training
Change in triglycerides
Blood test
Measured: Three months after starting training
Change in triglycerides
Blood test
Measured: Three months after finishing training
Changes in systolic blood pressure
Blood pressure monitor
Measured: Three months after starting training
Changes in systolic blood pressure
Blood pressure monitor
Measured: Three months after finishing training
Changes in body composition
The participant's weight will be taken with a calibrated scale
Measured: Three months after starting training
Changes in body composition
The participant's weight will be taken with a calibrated scale
Measured: Three months after finishing training
Changes in body composition
The participant's height will be taken with a tape measure
Measured: Three months after starting training
Changes in body composition
The participant's height will be taken with a tape measure
Measured: Three months after finishing training
Changes in waist circumference
The participant's waist circumference will be taken with a tape measure
Measured: Three months after starting training
Changes in waist circumference
The participant's waist circumference will be taken with a tape measure
Measured: Three months after finishing training
Changes in aerobic capacity
Will be done through the Navetta test
Measured: Three months after starting training
Changes in aerobic capacity
Will be done through the Navetta test
Measured: Three months after finishing training
Change in heart rate
It will be measured with a heart rate sensor, which indicates in real time the heart rate reached
Measured: Three months after starting training
Change in heart rate
It will be measured with a heart rate sensor, which indicates in real time the heart rate reached
Measured: Three months after finishing training
Change in resistance strength
It will be tested with repeated contractions for a period of time long enough for muscle fatigue to occur. The abdominal test will be performed in 60 seconds and the largest possible number of push-ups without rest will be performed
Measured: Three months after starting training
Change in resistance strength
It will be tested with repeated contractions for a period of time long enough for muscle fatigue to occur. The abdominal test will be performed in 60 seconds and the largest possible number of push-ups without rest will be performed
Measured: Three months after finishing training
Change in total insulin dose
Blood test
Measured: Three months after starting training
Change in total insulin dose
Blood test
Measured: Three months after finishing training
Frequency of hypoglycemia episodes during the training
A blood glucose meter will be used and trained to report episodes during workouts
Measured: Three months after starting training
Frequency of hypoglycemia episodes during the training
A blood glucose meter will be used and trained to report episodes during workouts
Measured: Three months after finishing training
Change in mood of adolescents
Application of the PHQ-9 questionnaire. This scale is graded into 4 categories: 0-4 (minimal), 5-9 (mild), 10-14 (moderate), 15-19 (moderate to severe), 20-27 (severe) (25). A score greater than or equal to 11 is recommended as a cut-off point to determine probable ED in the Chilean population of adolescents
Measured: Three months after starting training
Change in mood of adolescents
Application of the PHQ-9 questionnaire. This scale is graded into 4 categories: 0-4 (minimal), 5-9 (mild), 10-14 (moderate), 15-19 (moderate to severe), 20-27 (severe) (25). A score greater than or equal to 11 is recommended as a cut-off point to determine probable ED in the Chilean population of adolescents
Measured: Three months after finishing training
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Nov 2021
- Study start4 Sep 2021
- Primary completion4 Mar 2022
- Study completion4 Apr 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (29)Papers the sponsor has linked to this study.
- Other trials for Diabetes Mellitus, Type 1Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hospital Las Higueras
- Sponsor type
- University, hospital or other
- Collaborators
- Hospital Guillermo Grant Benavente, Centro de Vida Saludable, Universidad de Concepción
- Responsible party
- Principal investigator, JULIO SOTO BARROS, Hospital Las Higueras
- Investigators
- JULIO SOTO, MD, Principal investigator, Hospital Las Higueras
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05107544
- Sponsor's protocol ID
- 20-12-67
- Status last verified
- Feb 2024
- First submitted
- 11 Oct 2021
- Last updated
- 28 Feb 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Miller RG, Mahajan HD, Costacou T, Sekikawa A, Anderson SJ, Orchard TJ. A Contemporary Estimate of Total Mortality and Cardiovascular Disease Risk in Young Adults With Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care. 2016 Dec;39(12):2296-2303. doi: 10.2337/dc16-1162. Epub 2016 Sep 21.
PubMed 27654986Riddell, M., & Perkins B. (2006). Type 1 diabetes and vigorous exercise: Applications of exercise physiology to patient management. Canadian journal of diabetes, 30(1), 63-71.
MacMillan F, Kirk A, Mutrie N, Matthews L, Robertson K, Saunders DH. A systematic review of physical activity and sedentary behavior intervention studies in youth with type 1 diabetes: study characteristics, intervention design, and efficacy. Pediatr Diabetes. 2014 May;15(3):175-89. doi: 10.1111/pedi.12060. Epub 2013 Jul 29.
PubMed 23895512Katz M, Giani E, Laffel L. Challenges and Opportunities in the Management of Cardiovascular Risk Factors in Youth With Type 1 Diabetes: Lifestyle and Beyond. Curr Diab Rep. 2015 Dec;15(12):119. doi: 10.1007/s11892-015-0692-4.
PubMed 26520142Adolfsson P, Riddell MC, Taplin CE, Davis EA, Fournier PA, Annan F, Scaramuzza AE, Hasnani D, Hofer SE. ISPAD Clinical Practice Consensus Guidelines 2018: Exercise in children and adolescents with diabetes. Pediatr Diabetes. 2018 Oct;19 Suppl 27:205-226. doi: 10.1111/pedi.12755. No abstract available.
PubMed 30133095Kriska AM, LaPorte RE, Patrick SL, Kuller LH, Orchard TJ. The association of physical activity and diabetic complications in individuals with insulin-dependent diabetes mellitus: the Epidemiology of Diabetes Complications Study--VII. J Clin Epidemiol. 1991;44(11):1207-14. doi: 10.1016/0895-4356(91)90153-z.
PubMed 1941015Jabbour G, Henderson M, Mathieu ME. Barriers to Active Lifestyles in Children with Type 1 Diabetes. Can J Diabetes. 2016 Apr;40(2):170-2. doi: 10.1016/j.jcjd.2015.12.001.
PubMed 27038139Scott SN, Cocks M, Andrews RC, Narendran P, Purewal TS, Cuthbertson DJ, Wagenmakers AJM, Shepherd SO. High-Intensity Interval Training Improves Aerobic Capacity Without a Detrimental Decline in Blood Glucose in People With Type 1 Diabetes. J Clin Endocrinol Metab. 2019 Feb 1;104(2):604-612. doi: 10.1210/jc.2018-01309.
PubMed 30281094Scott SN, Shepherd SO, Strauss JA, Wagenmakers AJM, Cocks M. Home-based high-intensity interval training reduces barriers to exercise in people with type 1 diabetes. Exp Physiol. 2020 Apr;105(4):571-578. doi: 10.1113/EP088097. Epub 2019 Oct 25.
PubMed 31584734Reddy R, Wittenberg A, Castle JR, El Youssef J, Winters-Stone K, Gillingham M, Jacobs PG. Effect of Aerobic and Resistance Exercise on Glycemic Control in Adults With Type 1 Diabetes. Can J Diabetes. 2019 Aug;43(6):406-414.e1. doi: 10.1016/j.jcjd.2018.08.193. Epub 2018 Aug 30.
PubMed 30414785Clements MA, Foster NC, Maahs DM, Schatz DA, Olson BA, Tsalikian E, Lee JM, Burt-Solorzano CM, Tamborlane WV, Chen V, Miller KM, Beck RW; T1D Exchange Clinic Network. Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry. Pediatr Diabetes. 2016 Aug;17(5):327-36. doi: 10.1111/pedi.12295. Epub 2015 Jul 8.
PubMed 26153338Miller KM, Foster NC, Beck RW, Bergenstal RM, DuBose SN, DiMeglio LA, Maahs DM, Tamborlane WV; T1D Exchange Clinic Network. Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care. 2015 Jun;38(6):971-8. doi: 10.2337/dc15-0078.
PubMed 25998289Hasan R, Perez-Santiago D, Churilla JR, Montes B, Hossain J, Mauras N, Darmaun D. Can Short Bouts of Exercise ("Exercise Snacks") Improve Body Composition in Adolescents with Type 1 Diabetes? A Feasibility Study. Horm Res Paediatr. 2019;92(4):245-253. doi: 10.1159/000505328. Epub 2020 Jan 31.
PubMed 32007996Quirk H, Blake H, Dee B, Glazebrook C. "You can't just jump on a bike and go": a qualitative study exploring parents' perceptions of physical activity in children with type 1 diabetes. BMC Pediatr. 2014 Dec 20;14:313. doi: 10.1186/s12887-014-0313-4.
PubMed 25526774Francois ME, Baldi JC, Manning PJ, Lucas SJ, Hawley JA, Williams MJ, Cotter JD. 'Exercise snacks' before meals: a novel strategy to improve glycaemic control in individuals with insulin resistance. Diabetologia. 2014 Jul;57(7):1437-45. doi: 10.1007/s00125-014-3244-6. Epub 2014 May 10.
PubMed 24817675
Study at a glance
From the registry record, last updated by the sponsor on 28 Feb 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Metabolic, Physical Fitness and Mental Health Effects of High Intensity Interval Training (HIIT) in Adolescents With Type 1 Diabetes
- ClinicalTrials.gov ID
- NCT05107544
- Acronym / sponsor ID
- 20-12-67
- Conditions
- Diabetes Mellitus, Type 1
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- Hospital Las HiguerasUniversity, hospital or other
- Collaborators
- Hospital Guillermo Grant Benavente, Centro de Vida Saludable, Universidad de Concepción
- Study start
- 4 Sep 2021 (actual)
- Primary completion
- 4 Mar 2022 (actual)
- Study completion
- 4 Apr 2022 (actual)
- First posted
- 4 Nov 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Patients with type 1 diabetes usually present cardiovascular risk factors. Sixty percent of them are overweight or obese, 40% have hypertension, 60% have dyslipidemia, leading to cardiovascular disease as the major cause of death in adults with type 1 diabetes. Regular exercise can help patients to improve cardiovascular disease risk profile, metabolic control and chronic complications. Recommendations for exercise in children with diabetes are the same as the general population, between ages 8 to 18 years 60 min of physical exercise/day is suggested, including moderate or vigorous aerobic activity (at least 20 minutes), muscle strengthening and bone strengthening activities. Children with type 1 diabetes have poorer physical fitness levels than the non-diabetic peers and it has been described some barriers to meet these recommendations between children and adolescents with type 1 diabetes such as the fear of hypoglycemia, external temperature, work schedule, loss of control of diabetes, a low fitness level. The two types of exercise (aerobic and anaerobic) are recommended in people with diabetes. High intensity interval training involves alternation between brief periods of vigorous exercise and recovery at low to moderate intensity. Has been shown that HIIT is associated with improving aerobic capacity without a detrimental decline in blood glucose in adults with type 1 diabetes and home-based high-intensity interval training reduces barriers to exercise in the same group. The objective of the present study is to propose a HIIT exercise protocol through online modality to a group of adolescents with type 1 diabetes to evaluate the metabolic effects and physical capacity through an analytical, prospective and longitudinal study (before and after) for 3 months. As primary outcome is expected to improve metabolic control shown as an increase in time in range on continuous glucose monitoring and a decrease in glycosylated hemoglobin. And as secondary results, improve the aerobic capacity and resistance strength, lipid profile parameters, anthropometric and on the mood of the participants.
Detailed description
Hypothesis Three month HIIT training program increases time in range (TIR) and decreases glycemic variability (MAGE) in adolescents with DM1.
HIIT training program improves physical fitness (aerobic capacity and strength) of adolescents with DM1.
Methodology Analytical, prospective, longitudinal study (before and after). This type of study was chosen for ethical reasons. A group will not be left without intervention knowing the benefits of physical exercise in patients with DM1.
HIIT for 3 months
Population of study This study will be carried out with adolescents with type 1 diabetes treated at the sponsoring Hospitals: Las Higueras and Guillermo Grant Benavente.
A sample size of 30 Adolescents would be sufficient to detect a 15 percent increase in the percentage of time in the range of glucose values within the target range four months after the study start using a level of significance of 0.05% a power of 80% and a loss of follow-up of 15% (4 adolescents).
Type of sampling Convenience sampling
Procedures
Metabolic control monitoring Continuous glucose monitoring (CGM) will be used continuously during the study period. The duration of the CGM is going to be 7 days each time (Guardian Connect, Medtronic). If the patients are already wearing a CGM, will use the same device and data from these specific times will be collected for analysis.
Blood glucose will be monitored during exercise to make adjustments to therapy if necessary. This will be done by the doctors weekly for the first month and then every 15 days.
The statistical analysis of the continuous glucose monitoring (CGM) will be carried out in 4 moments: before starting the study, the first month after, at 3 months and 3 months after ending the training.
Blood sampling is going to be taken at baseline and at 3 month. will be measured HbA1c and lipid profile.
Total insulin dosing is going to be carefully recorded as units/kg/day during the study.
An insulin sensitivity score (ISS) is going to be calculated using the SEARCH ISS model: logeIS = 4.64725 - 0.02032 × (waist, cm) - 0.09779 × (HbA1c, %) - 0.00235 × (TG, mg/dL; R2 = 0.74 in the initial SEARCH model). This has been validated using the hyperinsulinemic euglycemic clamp, considered the gold standard for insulin sensitivity measures. CGM data are going to be downloaded and used to calculate percent blood glucose at, below, or above target.
The HbA1c and lipid profile will be measured using the Abbott brand model Architect c8000.
Nutritional assessment Nutritional consultation is going to be performed to the participants, in which it will be carried out a body composition analysis using the bioimpedianciometer TANITA TBF-40 at several times: before starting the intervention, at 1 month, at 3 months and at 3 months after finishing the intervention.
Two educational sessions will be performed to participants and parents and / or caregivers on carbohydrate content and glycemic index to reinforce the knowledge acquired throughout the course of the pathology in order to contribute to improve glycemic control. These will be carried out through a digital platform divided into groups of 10 or 15 participants.
In order to know the daily calorie intake and the distribution of macronutrients of the participants, the information from the 24-hour reminder questionnaire will be collected through a telephone call in 4 random days (without prior notice) during the same evaluation times mentioned previously.
Fitness monitoring Before intervention the participants are going to undergo physical evaluation: Cafra test, course-navette test, strength and Physical activity questionnaire for adolescents (PAQ-a) to determine their health-related fitness before applying the protocol. To standardize the sample and avoid cardiovascular risks due to the intensity of the effort, the Cafra test will be applied, which will enable the participant to perform the following tests. This test is used in the evaluation of physical education by the Education Quality Measurement System in the country. At the end of intervention aerobic capacity and resistance strength is going to be evaluated again.
The Cafra test goal is to determine the cardiovascular adaptive capacity of the participants from workloads of medium intensity during walking. If at the end of the test the individual has a heart rate equal to or greater than 160 beats per minute, he should not take the Navette test.
The Navette test is a cardiorespiratory fitness test. The moment in which the individual interrupts the test indicates the cardiorespiratory endurance. In addition, at the time this test is performed, blood pressure will be measured before and at the end, to rule out the presence of baseline or exercise-induced hypertension.
The heart rate will be measured with a heart rate sensor, which indicates in real time the heart rate reached, during the initial and final evaluations and during training sessions.
To evaluate muscular endurance, the abdominal test will be performed in 60 seconds and the largest possible number of push-ups without rest will be carried out. In this way, there will be a record of how the physical condition is before and after applying the protocol.
Adherence to physical training and nutritional consultations will be monitored through the online connection.
Physical training The training is going to have 2 phases, the initial phase and improvement phase, which are going to be differentiated according to work intensity following the recommendations of the American College of Sports Medicine. To prescribe the intensity of exercise karvonen formula is going to be used for which resting heart rate measured for a week is needed.
The methodology of work is going to be High intensity interval training (HIIT) using cardiovascular and endurance exercises using the own weight considering an intensity of 60-75% of the VO2max during the first 4 weeks (initial phase). The frequency of the training is 3 times a week under researcher online supervision between 3 to 7 pm Monday to Friday. During the improvement phase the intensity is going to increase to a 75-85% of the VO2max for 8 week. The intensity and effects of the training will be monitored thought heart rate sensors and the Borg Rating of Perceived Exertion Scale. Post-exercise monitoring, class coordination, reminders and motivation to participate will be performed by online group administered by the researchers.
Two physical education teachers will supervise each session.
Strategies to avoid acute changes in glycemia during training
It will be required that participants check the blood glucose by fingerstick before meals, before and after exercise, at bedtime, and twice a week around midnight.
The amount and type of food are not going to be controlled, but will be asked participants not exercising before or within 90 minutes after a meal . Considering that HIIT is associated to stable glycaemia no changes will be prescribed in fast-acting insulin dose.
For the management of blood glucose levels during the training period (before, during and after each session), a protocol based on the recommendations of the consensus for glycemia management during exercise using continuous glucose monitoring will be used.
Before starting and after completing each training session, a capillary blood glucose measurement will be requested as a safety measure and also in the event of symptoms of hypoglycemia or if the sensor shows or anticipates hypoglycemia.
In addition, when participants first start exercising, according to the midnight glycemia, it may be necessary to reduce the basal insulin dose by 20-50% on the day of exercise.
Participants using an insulin pump will use the same protocol, with a reduction in bolus doses and use of temporary basal on the days of exercise.
Mood evaluation The Patient Health Questionnaire 9 (PHQ-9) will be applied in its version for adolescents, which consists of nine questions designed to evaluate depressive symptoms according to DSM-5 criteria, on an ordinal scale according to the frequency of symptoms (never, some days, more than half of the days, almost every day). The score range is from 0 to 27 points, where higher values indicate a greater probability of a Depressive Episode. This scale is graded into 4 categories: 0-4 (minimal), 5-9 (mild), 10-14 (moderate), 15-19 (moderate to severe), 20-27 (severe). According to recent evidence, a score greater than or equal to 11 is recommended as a cut-off point to determine probable depressive episode in the Chilean population of adolescents. Patients who present a cut-off point higher than this in the initial evaluation will be excluded from protocol and will be referred to child psychiatry care.
To evaluate the effects of exercise on the depressed mood of adolescents, this survey will also be applied at the end of the intervention and 3 months after the intervention.
Blood Pressure Measurement In addition, during the initial evaluation, blood pressure will be measured before and after the physical tests to detect children with suspected hypertension, who as detailed above will be excluded from the intervention.
The BP recording will be carried out with an oscillometric device and the conditions for this procedure are: the adolescent must be seated, with the right arm uncovered, feet resting on the floor, and the BP cuff at the level of the heart. Before measuring the blood pressure the individual will need to remain sitting for at least five minutes. The blood pressure value will be evaluated according to the recommendations for the diagnosis of hypertension in children and adolescents of the American Academy of Pediatrics.
Statistical Analysis The initial analysis will examine data distribution through the Shapiro-Wilk test and baseline characteristics of all adolescents.
The quantitative variables will be expressed as means or medians, accompanied by deviation or interquartile ranges according to the exploration of normality. It will be analyzed each time of evaluation (transversal) using the chi-square test for categorical variables and the Student-t or Wilcoxon tests for continuous variables.
Relevant tests will be used to consider the non-dependence of the data obtained for both qualitative and quantitative analysis.
The effects of the treatment will be expressed , using mixed regression models (longitudinal) adjusting for potential confounders at baseline.
Subgroup analysis will be performed with interaction tests for relevant variables as BMI and socioeconomic status. Two separate definitions of compliance will be used. First, adolescents will be considered compliant to the HIIT treatment if participation is at least 75% of the number of training. Second, adolescents will be considered compliant to the HIIT if attendance is 100% of the counseling sessions to the nutritional and to endocrine consultations.
Outcome comparisons in the time will be analyzed intention-to-treat basis, regardless of whether is abandoned the study or fully adhere to the intervention. A secondary per-protocol analysis will be performed for the primary outcome including only the adolescents who were compliant with the protocol.
All analyses will follow a pre-specified statistical analysis plan. Stata v.14 software (StataCorp, College Station, TX) will be used for statistical analysis.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| High Intensity Interval Training | Experimental | Other: HIGH INTENSITY INTERVAL TRAININGThe entire group is going to be undergo the intervention |
Who may qualify
- Ages
- 12 to 19 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (6 listed)
- Adolescents with type 1 diabetes
- Ages: 12-19 years (and in pubertal stage of at least Tanner stage III breast or genitalia)
- HbA1c between 7 and 11.5%
- Total daily insulin dose ≥0.7 units/kg/day.
- Both genders
Key exclusion criteria (13 listed)
- < 1 year of diabetes
- Any medical, mental or physical disability that contraindicates exercise.
- Practice of regular, structured and planned physical exercise outside the project, more than 2 times a week.
- Pregnancy or breastfeeding
- > 1 episode of severe hypoglycemia in the last 6 months
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| HIGH INTENSITY INTERVAL TRAININGWill be prescribed HIIT through online modality to a group of adolescents with type 1 diabetes 3 times a week for 3 months. The training is going to have 2 phases, the initial phase and improvement phase, which are going to be differentiated according to work intensity following the recommendations of the American College of Sports Medicine. During the initial phase (first 4 weeks) the intensity is going to be 60-75% of the VO2 max. During the improvement phase the intensity is going to increase to a 75-85% of the VO2 max for 8 week. | Other | High Intensity Interval Training |
Primary outcome
Time change in range
Time frame: First month after starting training
Time in Range (TIR) is the percentage of time that a person spends with their blood glucose levels in a target range (70-180)
Time change in range
Time frame: Three months after starting training
Time in Range (TIR) is the percentage of time that a person spends with their blood glucose levels in a target range (70-180)
Time change in range
Time frame: Three months after finishing training
Time in Range (TIR) is the percentage of time that a person spends with their blood glucose levels in a target range (70-180)
26 secondary outcomes
Change in hemoglobin A1c
Time frame: Three months after starting training
Change in hemoglobin A1c
Time frame: Three months after finishing training
Change in cholesterol
Time frame: Three months after starting training
Change in cholesterol
Time frame: Three months after finishing training
Change in triglycerides
Time frame: Three months after starting training
Change in triglycerides
Time frame: Three months after finishing training
Changes in systolic blood pressure
Time frame: Three months after starting training
Changes in systolic blood pressure
Time frame: Three months after finishing training
Changes in body composition
Time frame: Three months after starting training
Changes in body composition
Time frame: Three months after finishing training
Changes in body composition
Time frame: Three months after starting training
Changes in body composition
Time frame: Three months after finishing training
Changes in waist circumference
Time frame: Three months after starting training
Changes in waist circumference
Time frame: Three months after finishing training
Changes in aerobic capacity
Time frame: Three months after starting training
Changes in aerobic capacity
Time frame: Three months after finishing training
Change in heart rate
Time frame: Three months after starting training
Change in heart rate
Time frame: Three months after finishing training
Change in resistance strength
Time frame: Three months after starting training
Change in resistance strength
Time frame: Three months after finishing training
Change in total insulin dose
Time frame: Three months after starting training
Change in total insulin dose
Time frame: Three months after finishing training
Frequency of hypoglycemia episodes during the training
Time frame: Three months after starting training
Frequency of hypoglycemia episodes during the training
Time frame: Three months after finishing training
Change in mood of adolescents
Time frame: Three months after starting training
Change in mood of adolescents
Time frame: Three months after finishing training
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Feb 2024.
- Background: PubMed 27654986Miller RG, Mahajan HD, Costacou T, Sekikawa A, Anderson SJ, Orchard TJ. A Contemporary Estimate of Total Mortality and Cardiovascular Disease Risk in Young Adults With Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care. 2016 Dec;39(12):2296-2303. doi: 10.2337/dc16-1162. Epub 2016 Sep 21.
- BackgroundRiddell, M., & Perkins B. (2006). Type 1 diabetes and vigorous exercise: Applications of exercise physiology to patient management. Canadian journal of diabetes, 30(1), 63-71.
- Background: PubMed 23895512MacMillan F, Kirk A, Mutrie N, Matthews L, Robertson K, Saunders DH. A systematic review of physical activity and sedentary behavior intervention studies in youth with type 1 diabetes: study characteristics, intervention design, and efficacy. Pediatr Diabetes. 2014 May;15(3):175-89. doi: 10.1111/pedi.12060. Epub 2013 Jul 29.
- Background: PubMed 26520142Katz M, Giani E, Laffel L. Challenges and Opportunities in the Management of Cardiovascular Risk Factors in Youth With Type 1 Diabetes: Lifestyle and Beyond. Curr Diab Rep. 2015 Dec;15(12):119. doi: 10.1007/s11892-015-0692-4.
- Background: PubMed 30133095Adolfsson P, Riddell MC, Taplin CE, Davis EA, Fournier PA, Annan F, Scaramuzza AE, Hasnani D, Hofer SE. ISPAD Clinical Practice Consensus Guidelines 2018: Exercise in children and adolescents with diabetes. Pediatr Diabetes. 2018 Oct;19 Suppl 27:205-226. doi: 10.1111/pedi.12755. No abstract available.
- Background: PubMed 1941015Kriska AM, LaPorte RE, Patrick SL, Kuller LH, Orchard TJ. The association of physical activity and diabetic complications in individuals with insulin-dependent diabetes mellitus: the Epidemiology of Diabetes Complications Study--VII. J Clin Epidemiol. 1991;44(11):1207-14. doi: 10.1016/0895-4356(91)90153-z.
- Background: PubMed 27038139Jabbour G, Henderson M, Mathieu ME. Barriers to Active Lifestyles in Children with Type 1 Diabetes. Can J Diabetes. 2016 Apr;40(2):170-2. doi: 10.1016/j.jcjd.2015.12.001.
- Background: PubMed 30281094Scott SN, Cocks M, Andrews RC, Narendran P, Purewal TS, Cuthbertson DJ, Wagenmakers AJM, Shepherd SO. High-Intensity Interval Training Improves Aerobic Capacity Without a Detrimental Decline in Blood Glucose in People With Type 1 Diabetes. J Clin Endocrinol Metab. 2019 Feb 1;104(2):604-612. doi: 10.1210/jc.2018-01309.
- Background: PubMed 31584734Scott SN, Shepherd SO, Strauss JA, Wagenmakers AJM, Cocks M. Home-based high-intensity interval training reduces barriers to exercise in people with type 1 diabetes. Exp Physiol. 2020 Apr;105(4):571-578. doi: 10.1113/EP088097. Epub 2019 Oct 25.
- Background: PubMed 30414785Reddy R, Wittenberg A, Castle JR, El Youssef J, Winters-Stone K, Gillingham M, Jacobs PG. Effect of Aerobic and Resistance Exercise on Glycemic Control in Adults With Type 1 Diabetes. Can J Diabetes. 2019 Aug;43(6):406-414.e1. doi: 10.1016/j.jcjd.2018.08.193. Epub 2018 Aug 30.
- Background: PubMed 26153338Clements MA, Foster NC, Maahs DM, Schatz DA, Olson BA, Tsalikian E, Lee JM, Burt-Solorzano CM, Tamborlane WV, Chen V, Miller KM, Beck RW; T1D Exchange Clinic Network. Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry. Pediatr Diabetes. 2016 Aug;17(5):327-36. doi: 10.1111/pedi.12295. Epub 2015 Jul 8.
- Background: PubMed 25998289Miller KM, Foster NC, Beck RW, Bergenstal RM, DuBose SN, DiMeglio LA, Maahs DM, Tamborlane WV; T1D Exchange Clinic Network. Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care. 2015 Jun;38(6):971-8. doi: 10.2337/dc15-0078.
- Individual participant dataSharing planned: No
Related trials for Diabetes Mellitus, Type 1
Not yet recruitingPhase 3
A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes
Obesity, Overweight
RecruitingPhase 1
Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma
Melanoma
Active, not recruitingPhase 2
A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer
Metastatic Colorectal Cancer
Not yet recruiting
Inter-Arm Differences in Continuous Glucose Monitor Readings in Adults With Diabetes
Continuous Glucose Monitoring, Type 1 Diabetes
RecruitingObservational study
Estimated Risk of Preeclampsia in the First Trimester and Its Association With Subclinical Atherosclerosis and Cardiovascular Risk in Women With Type 1 Diabetes
Type 1 Diabetes, Preeclampsia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
JULIO SOTO, MD principal investigator
Hospital Las Higueras
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing HIGH INTENSITY INTERVAL TRAINING in people with Diabetes Mellitus, Type 1, run by Hospital Las Higueras at 1 site in Chile.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Chile. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Time change in range (time frame: First month after starting training). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05107544, which also lists 29 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2024.